TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,952,032 | -56.3% | 951,200 | +29.8% | 0.02% | -56.5% |
| Q2 2023 | $18,197,784 | +131.1% | 732,600 | +39.9% | 0.05% | +130.0% |
| Q1 2023 | $7,874,944 | +91.7% | 523,600 | +50.8% | 0.02% | +81.8% |
| Q4 2022 | $4,108,559 | +239.0% | 347,300 | +69.7% | 0.01% | +175.0% |
| Q3 2022 | $1,212,000 | +90.9% | 204,700 | +37.0% | 0.00% | +100.0% |
| Q2 2022 | $635,000 | -16.9% | 149,400 | +86.1% | 0.00% | 0.0% |
| Q1 2022 | $764,000 | +101.1% | 80,300 | +1000.0% | 0.00% | +100.0% |
| Q4 2020 | $380,000 | +4.7% | 7,300 | -83.8% | 0.00% | 0.0% |
| Q1 2019 | $363,000 | +58.5% | 45,200 | -19.0% | 0.00% | 0.0% |
| Q4 2018 | $229,000 | -5.0% | 55,800 | +29.8% | 0.00% | 0.0% |
| Q3 2018 | $241,000 | -64.8% | 43,000 | -17.5% | 0.00% | -50.0% |
| Q2 2018 | $685,000 | +57.1% | 52,100 | +69.7% | 0.00% | +100.0% |
| Q1 2018 | $436,000 | +260.3% | 30,700 | +201.0% | 0.00% | – |
| Q3 2017 | $121,000 | -2.4% | 10,200 | -17.1% | 0.00% | – |
| Q2 2017 | $124,000 | – | 12,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |